NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration

Molecular Neurodegeneration

Volumn 5, Issue 1, 2010, Pages

  Kwak, Young Don ^a   Ma, Tao ^a,c   Diao, Shiyong ^a   Zhang, Xue ^b   Chen, Yaomin ^b   Hsu, Janet ^b   Lipton, Stuart A ^b,d   Masliah, Eliezer ^d   Xu, Huaxi ^b   Liao, Francesca Fang ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b BURNHAM INSTITUTE   (United States)

^c NANJING MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; NITRIC OXIDE; PHOSPHATIDATE PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEASOME; PROTEIN KINASE B; S NITROSOCYSTEINE; UBIQUITIN PROTEIN LIGASE NEDD4;

AGED; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; HUMAN; HUMAN TISSUE; MOUSE; NERVE CELL; NERVE DEGENERATION; NITROSYLATION; NONHUMAN; OXIDATION REDUCTION STATE; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN MODIFICATION; PROTEIN STABILITY; RAT; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 78149253527     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-5-49     Document Type: Article

References (51)

1. PTEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. MP Myers JP Stolarov C Eng J Li SI Wang MH Wigler R Parsons NK Tonks, Proc Natl Acad Sci USA 1997 94 9052 9057 10.1073/pnas.94.17.9052 9256433
2. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. T Maehama JE Dixon, J Biol Chem 1998 273 13375 13378 10.1074/jbc.273.22.13375 9593664
3. A role for nuclear PTEN in neuronal differentiation. MB Lachyankar N Sultana CM Schonhoff P Mitra W Poluha S Lambert PJ Quesenberry NS Litofsky LD Recht R Nabi SJ Miller S Ohta BG Neel AH Ross, J Neurosci 2000 20 1404 1413 10662831
4. Negative regulation of neuronal stem/progenitor cell proliferation by the PTEN tumor suppressor gene in vivo. M Groszer R Erickson DD Scripture-Adams R Lesche A Trumpp JA Zack HI Kornblum X Liu H Wu, Science 2001 294 2186 2189 10.1126/science.1065518 11691952
5. Deletion of PTEN in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. SA Backman V Stambolic A Suzuki J Haight A Elia J Pretorius MS Tsao P Shannon B Bolon GO Ivy TW Mak, Nat Genet 2001 29 396 403 10.1038/ng782 11726926
6. Phosphatase PTEN in neuronal injury and brain disorders. N Chang YH El-Hayek E Gomez Q Wan, Trends in Neurosci 2007 30 581 586 10.1016/j.tins.2007. 08.006 (Pubitemid 350051425)
7. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. KK Park K Liu Y Hu PD Smith C Wang B Cai B Xu L Connolly I Kramvis M Sahin Z He, Science 2008 322 963 966 10.1126/science.1161566 18988856
8. E3 ligase Nedd4 promotes axon branching by downregulating PTEN. J Drinjakovic H Jung DS Campbell L Strochlic A Dwivedy CE Holt, Neuron 2010 65 341 357 10.1016/j.neuron.2010.01.017 20159448
9. Dlg1-PTEN interaction regulates myelin thickness to prevent damaging peripheral nerve overmyelination. L Cotter M Ozçelik C Jacob JA Pereira V Locher R Baumann JB Relvas U Suter N Tricaud, Science 2010 328 1415 1418 10.1126/science.1187735 20448149
10. Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse. SP Ji Y Zhang J Van Cleemput W Jiang M Liao L Li Q Wan JR Backstrom X Zhang, Nat Med 2006 12 324 329 10.1038/nm1349 16474401
11. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. RJ Griffin A Moloney M Kelliher JA Johnston R Ravid P Dockery R O'Connor C O'Neill, J Neurochem 2005 93 105 117 10.1111/j.1471-4159.2004. 02949.x 15773910
12. PTEN levels in Alzheimer's disease medial temporal cortex. A Rickle N Bodfanovic I Volkmann X Zhou JJ Pei B Winblad RF Cowburn, Neurochem Int 2006 48 114 123 10.1016/j.neuint.2005.08.014 16239049
13. Tumor-suppressor PTEN affects tau phosphorylation, aggregation, and binding to microtubules. X Zhang F Li A Bulloj YW Zhang G Tong Z Zhang FF Liao H Xu, FASEB J 2006 20 1272 1274 10.1096/fj.06-5721fje 16645045
14. Post-translational regulation of PTEN. X Wang X Jiang, Oncogene 2008 27 5454 5463 10.1038/onc.2008.242 18794880
15. Functional interaction of phosphatase and tensin homologue (PTEN) with the E3 ligase NEDD4-1 during neuronal response to zinc. YD Kwak B Wang W Pan H Xu X Jiang FF Liao, J Biol Chem 2010 285 9847 9857 10.1074/jbc.M109.091637 20100827
16. Phosphorylation of the PTEN tail regulates protein stability and function. F Vazquez S Ramaswamy N Nakamura WR Sellers, Mol Cell Biol 2000 20 5010 5018 10.1128/MCB.20.14.5010-5018.2000 10866658
17. PTEN is destabilized by phosphorylation on Thr 366. H Maccario NM Perera L Davidson CP Downes NR Leslie, Biochem J 2007 405 439 444 10.1042/BJ20061837 17444818
18. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. X Wang LC Trotman T Koppie A Alimonti Z Chen Z Gao J Wang H Erdjument-Bromage P Tempst C Cordon-Cardo PP Pandolfi X Jiang, Cell 2007 128 129 139 10.1016/j.cell.2006.11. 039 17218260
19. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. NR Leslie D Bennett YE Lindsay H Stewart A Gray CP Downes, EMBO J 2003 22 5501 5510 10.1093/emboj/cdg513 14532122
20. Redox regulation of PTEN by S-nitrosothiols. CX Yu S Li AR Whorton, Mol Pharmacol 2005 68 847 854 15967877
21. Akt activation by arachidonic acid metabolism occurs via oxidation and inactivation of PTEN tumor suppressor. TM Covey K Edes FA Fitzpatrick, Oncogene 2007 26 5784 5792 10.1038/sj.onc.1210391 17369849
22. Reversible inactivation of the tumor suppressor PTEN by H2O2. SR Lee KS Yang J Kwon C Lee W Jeong SG Rhee, J Biol Chem 2002 277 20336 20342 10.1074/jbc.M111899200 11916965
23. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. J Kwon SR Lee KS Yang Y Ahn YJ Kim ER Stadtman SG Rhee, Proc Natl Acad Sci USA 2004 101 16419 16424 10.1073/pnas.0407396101 15534200
24. Protein S-nitrosylation in health and disease: a current perspective. MW Foster DT Hess JS Stamler, Trends Mol Med 2009 15 391 404 10.1016/j.molmed.2009. 06.007 19726230
25. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. J Haendeler J Hoffmann V Tischler BC Berk AM Zeiher S Dimmeler, Nat Cell Biol 2002 4 743 749 10.1038/ncb851 12244325
26. Hydrogen peroxide inhibits mTOR signaling by activation of AMPKalpha leading to apoptosis of neuronal cells. L Chen B Xu L Liu Y Luo J Yin H Zhou W Chen T Shen X Han S Huang, Lab Invest 2010 90 762 773 10.1038/labinvest.2010.36 20142804
27. PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning. Z Cai GL Semenza, Circ Res 2005 97 1351 1359 10.1161/01.RES.0000195656.52760.30 16284183
28. Cerebral preconditioning and ischaemic tolerance. JM Gidday, Nat Rev Neurosci 2006 7 437 448 10.1038/nrn1927 16715053
29. Ischemic postconditioning as a novel avenue to protect against brain injury after stroke. H Zhao, J Cereb Blood Flow Metab 2009 29 873 885 10.1038/jcbfm.2009.13 19240739
30. Nitric oxide in cell survival: a janus molecule. V Calabrese C Cornelius E Rizzarelli JB Owen AT Dinkova-Kostova DA Butterfield, Antioxid Redox Signal 2009 11 2717 2739 10.1089/ars.2009.2721 19558211
31. Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. MA Smith X Zhu M Tabaton G Liu DW McKeel Jr ML Cohen X Wang SL Siedlak BE Dwyer T Hayashi M Nakamura A Nunomura G Perry, J Alzheimers Dis 2010 19 363 372 20061651
32. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. JO Lee H Yang MM Georgescu A Di Cristofano T Maehama Y Shi JE Dixon P Pandolfi NP Pavletich, Cell 1999 99 323 334 10.1016/S0092-8674(00)81663-3 10555148
33. Phosphorylation keeps PTEN phosphatase closed for business. AH Ross A Gericke, Proc Natl Acad Sci USA 2009 106 1297 1398 10.1073/pnas.0812473106 19174524
34. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. D Yao Z Gu T Nakamura ZQ Shi Y Ma B Gaston LA Palmer EM Rockenstein Z Zhang E Masliah T Uehara SA Lipton, Proc Natl Acad Sci USA 2004 101 10810 10814 10.1073/pnas.0404161101 15252205
35. S-nitrosylation of IRP2 regulates its stability via the ubiquitin-proteasome pathway. S Kim SS Wing P Ponka, Mol Cell Biol 2004 24 330 337 10.1128/MCB.24.1.330-337.2004 14673166
36. Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins. CM Lee BY Kim L Li ET Morgan, J Biol Chem 2008 283 889 898 10.1074/jbc.M708821200 17993647
37. Role of S-nitrosylation in apoptosis resistance and carcinogenesis. AK Iyer N Azad L Wang Y Rojanasakul, Nitric Oxide 2008 19 146 151 10.1016/j.niox.2008.04.019 18474261
38. Nitric oxide regulates lung carcinoma cell anoikis through inhibition of Ubiquitin-proteasomal degradation of caveolin-1. P Chanvorachote U Nimmannit Y Lu S Talbott BH Jiang Y Rojanasakul, J Biol Chem 2009 284 28476 28484 10.1074/jbc.M109.050864 19706615
39. GSK-3 is essential in the pathogenesis of Alzheimer's disease. A Takashima, J Alzheimers Dis 2006 9 3 Suppl 309 317 16914869
40. CK2 is a novel negative regulator of NADPH oxidase and a neuroprotectant in mice after cerebral ischemia. GS Kim JE Jung K Niizuma PH Chan, J Neurosci 2009 29 14779 14789 10.1523/JNEUROSCI.4161-09.2009 19940173
41. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. F Liu I Grundke-Iqbal K Iqbal CX Gong, Eur J Neurosci 2005 22 1942 1950 10.1111/j.1460-9568.2005.04391.x 16262633
42. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes? E Steen BM Terry EJ Rivera JL Cannon TR Neely R Tavares XJ Xu JR Wands SM de la Monte, J Alzheimers Dis 2005 7 63 80 15750215 (Pubitemid 40387185)
43. Role of protein kinase B in Alzheimer's neurofibrillary pathology. JJ Pei S Khatoon WL An M Nordlinder T Tanaka H Braak I Tsujio M Takeda I Alafuzoff B Winblad RF Cowburn I Grundke-Iqbal K Iqbal, Acta Neuropathol 2003 105 381 392 12624792
44. PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury? MM Mocanu DM Yellon, Br J Pharmacol 2007 150 833 838 10.1038/sj.bjp.0707155 17293884
45. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. T Nagoshi T Matsui T Aoyama A Leri P Anversa L Li W Ogawa F del Monte JK Gwathmey L Grazette BA Hemmings DA Kass HC Champion A Rosenzweig, J Clin Invest 2005 115 2128 2138 10.1172/JCI23073 16007268
46. Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR. CY Wang HH Kim Y Hiroi N Sawada S Salomone LE Benjamin K Walsh MA Moskowitz JK Liao, Sci Signal 2009 2 62 a11 10.1126/scisignal.2000143 19293429
47. Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities. MM Fraser IT Bayazitov SS Zakharenko SJ Baker, Neuroscience 2008 151 476 488 10.1016/j.neuroscience.2007.10.048 18082964
48. Statin's excitoprotection is mediated by sAPP and the subsequent attenuation of calpain-induced truncation events, likely via rho-ROCK signaling. T Ma Y Zhao YD Kwak Z Yang R Thompson Z Luo H Xu FF Liao, J Neurosci 2009 29 11226 11236 10.1523/JNEUROSCI.6150-08.2009 19741129
49. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. SZ Lei ZH Pan SK Aggarwal HS Chen J Hartman NJ Sucher SA Lipton, Neuron 1992 8 1087 1099 10.1016/0896-6273(92)90130-6 1376999
50. The biotin switch method for the detection of S-nitrosylated proteins. SR Jaffrey SH Synder, Sci STKE 2001 2001 l1 10.1126/stke.2001.86.pl1 11752655
51. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. K Podsypanina LH Ellenson A Nemes J Gu M Tamura KM Yamada C Cordon-Cardo G Catoretti PE Fisher R Parsons, Proc Natl Acad Sci USA 1999 96 1563 1568 10.1073/pnas.96.4.1563 9990064